Price (delayed)
$8.3
Market cap
$2.05B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.4
Enterprise value
$2.67B
Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a
There are no recent dividends present for PACB.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.